Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $4.46 and traded as high as $4.54. Evotec shares last traded at $4.52, with a volume of 144,228 shares traded.
Evotec Stock Performance
The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The stock’s 50-day simple moving average is $4.46 and its two-hundred day simple moving average is $4.17. The stock has a market cap of $1.49 billion, a price-to-earnings ratio of 11.02 and a beta of 0.98.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Further Reading
- Five stocks we like better than Evotec
- ESG Stocks, What Investors Should Know
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How Investors Can Find the Best Cheap Dividend Stocks
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Which Wall Street Analysts are the Most Accurate?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
